Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71976 - 72000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NUSAP1	51203	upregulated	Silicon Dioxide results in increased expression of NUSAP1 mRNA	15q14	A24196
Silicon dioxide	Approved	NUTM1	256646	upregulated	Silicon Dioxide analog results in increased expression of NUTM1 mRNA	15q14	A24194
Silicon dioxide	Approved	NUTM2D	728130	upregulated	Silicon Dioxide analog results in increased expression of NUTM2D mRNA	10q23.2	A24195
Silicon dioxide	Approved	NXNL1	115861	upregulated	Silicon Dioxide analog results in increased expression of NXNL1 mRNA	19p13.11	A24195
Silicon dioxide	Approved	NYAP1	222950	upregulated	Silicon Dioxide analog results in increased expression of NYAP1 mRNA	7q22.1	A24195
Silicon dioxide	Approved	NYAP2	57624	downregulated	Silicon Dioxide analog results in decreased expression of NYAP2 mRNA	2q36.3	A24194
Silicon dioxide	Approved	NYNRIN	57523	downregulated	Silicon Dioxide analog results in decreased expression of NYNRIN mRNA	14q12	A24195
Silicon dioxide	Approved	OAS1	4938	upregulated	Silicon Dioxide results in increased expression of OAS1 mRNA	12q24.2	A24197 A24196
Silicon dioxide	Approved	OAS2	4939	upregulated	Silicon Dioxide results in increased expression of OAS2 mRNA	12q24.13	A24197 A24196
Silicon dioxide	Approved	OAS3	4940	upregulated	Silicon Dioxide results in increased expression of OAS3 mRNA	12q24.13	A24197 A24196
Silicon dioxide	Approved	OASL	8638	upregulated	Silicon Dioxide analog results in increased expression of OASL mRNA	12q24.31	A24195
Silicon dioxide	Approved	OASL	8638	upregulated	Silicon Dioxide results in increased expression of OASL mRNA	12q24.31	A24197 A24196
Silicon dioxide	Approved	OBSCN	84033	upregulated	Silicon Dioxide analog results in increased expression of OBSCN mRNA	1q42.13	A24195
Silicon dioxide	Approved	OBSL1	23363	downregulated	Silicon Dioxide analog results in decreased expression of OBSL1 mRNA	2q35	A24195
Silicon dioxide	Approved	OCA2	4948	downregulated	Silicon Dioxide analog results in decreased expression of OCA2 mRNA	15q12-q13.1	A24195
Silicon dioxide	Approved	OCEL1	79629	downregulated	Silicon Dioxide analog results in decreased expression of OCEL1 mRNA	19p13.11	A24195
Silicon dioxide	Approved	ODC1	4953	upregulated	Silicon Dioxide analog results in increased expression of ODC1 mRNA	2p25.1	A24195
Silicon dioxide	Approved	ODF3L2	284451	downregulated	Silicon Dioxide analog results in decreased expression of ODF3L2 mRNA	19p13.3	A24195
Silicon dioxide	Approved	OGDH	4967	upregulated	Silicon Dioxide results in increased expression of OGDH mRNA	7p13	A24196
Silicon dioxide	Approved	OGFR	11054	upregulated	Silicon Dioxide results in increased expression of OGFR mRNA	20q13.33	A24196
Silicon dioxide	Approved	OGFRL1	79627	upregulated	Silicon Dioxide analog results in increased expression of OGFRL1 mRNA	6q13	A24195
Silicon dioxide	Approved	OGG1	4968	downregulated	Silicon Dioxide results in decreased expression of OGG1 mRNA	3p25.3	A24196
Silicon dioxide	Approved	OGT	8473	downregulated	Silicon Dioxide results in decreased expression of OGT mRNA	Xq13.1	A24196
Silicon dioxide	Approved	OIP5	11339	downregulated	Silicon Dioxide analog results in decreased expression of OIP5 mRNA	15q15.1	A24194 A24195
Silicon dioxide	Approved	OLAH	55301	upregulated	Silicon Dioxide results in increased expression of OLAH mRNA	10p13	A24196

Displaying entries 71976 - 72000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability